Effect of Mirabegron on Promoting Brown Adipose Tissue Activation
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
In previous preclinical studies, our group found that Mirabegron, a clinical drug, could
activate brown adipose tissue and inhibit tumor growth in tumour-bearing mice.Investigators
look forward to further evaluating the effect of Mirabegron-mediated brown adipose tissue
activation, so as to provide new drug applications for clinical cancer prevention and
treatment